CD4 and neoplasm: In the next step, the effect of this nanobody produced in a mouse model of breast cancer was investigated, and the results showed that administration of this nanobody increased the number of T cells (both CTLs and CD4 +) in the tumor environment, but the CD4 + / CD8 + T cell ratio decreased in the anti-CD3 nanobody receiving group.